AptarGroup (AptarGroup) Debt-to-Asset : 0.27 (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is AptarGroup Debt-to-Asset?

AptarGroup's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $458 Mil. AptarGroup's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $726 Mil. AptarGroup's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was $4,452 Mil. AptarGroup's debt to asset for the quarter that ended in Dec. 2023 was 0.27.

AptarGroup Debt-to-Asset Historical Data

The historical data trend for AptarGroup's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AptarGroup Debt-to-Asset Chart

AptarGroup Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.35

0.31

0.30

0.29

0.27

AptarGroup Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Asset	Get a 7-Day Free Trial															0.29	0.29	0.29	0.28	0.27

Competitive Comparison of AptarGroup's Debt-to-Asset

For the Medical Instruments & Supplies subindustry, AptarGroup's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AptarGroup's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AptarGroup's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where AptarGroup's Debt-to-Asset falls into.

AptarGroup Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

AptarGroup's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(458.22	+	726.455)	/	4451.89
	=	0.27

AptarGroup's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(458.22	+	726.455)	/	4451.89
	=	0.27

AptarGroup (NYSE:ATR) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

AptarGroup Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of AptarGroup's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

AptarGroup (AptarGroup) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AptarGroup Inc (NYSE:ATR) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

AGT:Germany AGT:Germany

Address

265 Exchange Drive, Suite 301, Crystal Lake, IL, USA, 60014

Website

https://www.aptar.com

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, and closures to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (50% of sales) and the United States (33%), Aptar aims to increase its presence in Asia (10%) and Latin America (7%). Aptar's pharmaceutical division generates roughly one third of group sales but over two thirds of group profits.

Executives

Marc Prieur	officer: Segment President	265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Monnas Giovanna Kampouri	director	C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Sarah Js Glickman	director	60 BINNEY STREET, C/O BLUEBIRD BIO, INC., CAMBRIDGE MA 02142
George L Fotiades	director	281 SUMMIT AVENUE, SUMMIT NJ 07901
Hedi Tlili	officer: Segment President	265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Kimberly Chainey	officer: EVP and General Counsel	265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Xiangwei Gong	officer: President, Asia	265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60010
Shiela Vinczeller	officer: Chief Human Resource Officer	265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Julie Xing	director	265 EXCHANGE DRIVE, SUITE 301, CRYSTAL LAKE IL 60014
Maritza Gomez Montiel	director	C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Robert Kuhn	officer: EVP & CFO	C/O APTARGROUP 475 W. TERRA COTTA AVENUE, SUITE E, CRYSTAL LAKE IL 60014
Matthew L. Trerotola	director	2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON DE 19808
Gael Touya	officer: Segment President	475 W. TERRA COTTA AVE., SUITE E, CRYSTAL LAKE IL 60014
Candace S. Matthews	director	C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Isabel Marey-semper	director	C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014